New Rules set by NPPA to stop misuse of stents

  • News
  • December 25, 2017

In February 2017 The National Pharmaceuticals Pricing Authority (NPPA) reduced stent prices up to 80% for all drug-eluting stents and bioresorbable vascular scaffolds, But the generated invoices of angioplasty surgery still not come down to the expected level and the government received a number of complaints regarding the same.

The NPPA took the second step to provide transparency and to control prices further has issued a special circular to hospitals and the Food and Drug Administration (FDA) on Monday.

The new notice made a display of prices mandatory in their premises, as well as in a patient’s bill with the clear display of state stent types, brands, manufacturers and prices and the bills must also include details of type and price of stent used. FDA needs to ensure the implementation of the latest issue and keep an eye on the hospitals. Hospitals should also need to put up details about stents on their websites also.

Vidyadhar Jawadekar, Pune region’s joint commissioner for FDA (drug) confirmed the receiving of the fresh circular from NPPA and said they will implement it now.

  • Related Posts

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

    • News
    • May 27, 2025
    • 291 views
    Ramping Up Community for JeevanRaksha during Disasters

    CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra